Company: OPGN
Filing Date: 2025-08-21
Form Type: 10-K
Source: 0001829126-25-006628
Chunk: 618

Company: OPGEN INC
Filing Date: 2025-08-21
Form: 10-K
Item: Item 2
Chunk 618
---
991,529

    Accumulated deficit

    (293,500,522
    )

    (305,493,302
    )
  
    Accumulated other comprehensive loss

    -

    (75,138
    )
  
    Total stockholders’ equity (deficit)

    7,380,628

    (11,561,584
    )
  
    Total liabilities and stockholders’ equity (deficit)
     
    $
    9,862,698

    $
    1,882,274

See accompanying notes to consolidated financial statements.

F-5

OpGen, Inc.

Consolidated Statements of Operations and
Comprehensive Income (Loss)

    Year Ended December 31,

    2024

    2023

    Revenue

    Product sales
     
    $
    169,373

    $
    2,400,053

    Laboratory services

    26,776

    153,719

    Listing sponsorship services

    5,000,000

    -

    Collaboration revenue

    -

    864,548

    Total revenue

    5,196,149

    3,418,320

    Operating expenses

    Cost of products sold

    31,636

    3,084,075

    Cost of services

    1,575

    424,939

    Research and development, net

    48,820

    4,732,851

    General and administrative

    4,542,025

    8,081,664

    Sales and marketing

    172,238

    2,783,268

    Impairment of right-of-use asset

    -

    849,243

    Impairment of property and equipment

    -

    1,231,874

    Loss on deconsolidation of subsidiaries

    75,138

    12,979,061

    Total operating expenses

    4,871,432

    34,166,975

    Operating income (loss)

    324,717

    (30,748,655
    )
  
    Other income (expense)

    Interest and other income, net

    371,444

    142,488

    Interest expense

    (7,555
    )

    (1,838,933
    )
  
    Gain on extinguishment of debt